Rapamune Improves Outcomes of Severe H1N1 Pneumonia
NCT01620307
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
H1N1 Pneumonia
Hypoxemia
Interventions
DRUG:
Sirolimus (Rapamune 2mg/day, Pfizer)
Sponsor
Chang Gung Memorial Hospital